Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: A randomised and double-blinded clinical trial

European Radiology

Volumn 22, Issue 9, 2012, Pages 1998-2006

  Tepe, Gunnar ^a,d   Bantleon, Rüdiger ^a   Brechtel, Klaus ^a   Schmehl, Jörg ^a   Zeller, Thomas ^b   Claussen, Claus D ^a   Strobl, Frederik F ^a,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Klinikum Rosenheim   (Germany)

Author keywords

Antiplatelet therapy; Clopidogrel resistance; Endovascular therapy; Peripheral arterial disease; Platelet activation

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; CD40 LIGAND; CLOPIDOGREL; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; TARGET LESION REVASCULARISATION; THROMBOCYTE ACTIVATION;

AGED; ANGIOPLASTY; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84864685270     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2441-2     Document Type: Article

References (34)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:5-67
2. Chan AW, Moliterno DJ, Berger PB et al (2003) Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: Results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol 42:1188-1195
3. Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCICURE study. Lancet 358:527-533
4. Steinhubl SR, Berger PB, Mann JT 3rd et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288:2411-2420
5. The CAPRIE Steering Committee (1996) A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348:1329-1339
6. Dörffler-Melly J, Koopman MM, Prins MH, Büller HR (2005) Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev 1:CD002071
7. Davì G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482-2494
8. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227-1234
9. Chandrasekar B, Tanguay JF (2000) Platelets and restenosis. J Am Coll Card 35:555-562
10. Cassar K, Ford I, Greaves M, Bachoo P, Brittenden J (2005) Randomized clinical trial of the antiplatelet effects of aspirinclopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg 92:159-165
11. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J (2005) Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty. J Vasc Surg 42:252-258
12. Burdess A, Nimmo AF, Garden OJ et al (2010) Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg 252:37-42
13. Geisler T, Langer H, Wydymus M et al (2006) Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27:2420-2425
14. Hochholzer W, Trenk D, Bestehorn HP et al (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742-1750
15. Sibbing D, Morath T, Braun S et al (2010) Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 103:151-159
16. Tepe G, Schmehl J, Wendel HP et al (2006) Reduced thrombogenicity of nitinol stents-in vitro evaluation of different surface modifications and coatings. Biomaterials 27:643-650
17. Kaplan KL, Owen J (1981) Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199-202
18. Henn V, Slupsky JR, Gräfe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
19. Soga Y, Yokoi H, Kawasaki T et al (2009) Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol 53:48-53
20. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J (2006) Variability in responsiveness to clopidogrel in patients with intermittent claudication. Eur J Vasc Endovasc Surg 32:71-75
21. Ziegler S, Maca T, Alt E, Speiser W, Schneider B, Minar E (2002) Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Platelets 13:493-497
22. Linnemann B, Schwonberg J, Toennes SW, Mani H, Lindhoff-Last E (2010) Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease. Atherosclerosis 209:504-509
23. Ciuffetti G, Lombardini R, Pirro M, Lupattelli G, Mannarino E (2001) Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis. Clin Hemorheol Microcirc 25:31-39
24. Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP (2004) The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 15:117-125
25. Wilson AM, Brittenden J, Bachoo P, Ford I, Nixon GF (2009) Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty. J Vasc Surg 50:861-869
26. Schillinger M, Sabeti S, Loewe C et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879-1888
27. Krankenberg H, Schlüter M, Steinkamp HJ et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 116:285-292
28. Capek P, McLean GK, Berkowitz HD (1991) Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83:I70-I80
29. Berger PB, Bhatt DL, Fuster Vet al (2010) Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation 121:2575-2583
30. Bonello L, Camoin-Jau L, Arques S et al (2008) Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study. J Am Coll Cardiol 51:1404-1411
31. Aleil B, Jacquemin L, De Poli F et al (2008) Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: Results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. JACC Cardiovasc Interv 1:631-638
32. Pena A, Collet JP, Hulot JS et al (2009) Can we override clopidogrel resistance? Circulation 119:2854-2857
33. Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001-2015
34. Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045-1057